Condition
Chronic Myeloid Leukemia, BCR-ABL1 Positive clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Chronic Myeloid Leukemia, BCR-ABL1 Positive clinical trials that are recruiting, in United States. By phase: Phase 2 (4), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1Country
Newest Chronic Myeloid Leukemia, BCR-ABL1 Positive clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Impact of Targeted Therapy on Cancer-Related Cognitive Impairment | — | Rochester, New York | Recruiting | Jun 10, 2026 |
| Vaccination to prevent CMV infection in stem cell transplant patients | Phase 2 | Duarte, California and 2 other locations | Recruiting | Sep 28, 2023 |
| Using cord blood transplant and chemotherapy to treat high-risk blood cancers | Phase 2 | Seattle, Washington | Recruiting | Aug 28, 2023 |
| Reduced-intensity conditioning to lower treatment-related mortality in stem cell transplant patients | Phase 2 | Philadephia, Pennsylvania | Recruiting | Sep 2, 2021 |
| Donor stem cell transplant with chemotherapy and radiation for blood cancers | Phase 2 | Seattle, Washington | Recruiting | Dec 12, 2019 |
| HA-1 TCR T cell therapy for leukemia that returned or didn't respond after a donor stem cell transplant | Phase 1 | Seattle, Washington | Recruiting | Oct 31, 2017 |
All recruiting trials (6)
-
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
This study checks whether brain health and well‑being differ for people with leukemia who are starting or on TKI therapy compared with similar individuals without cancer or TKI exposure.
-
Vaccination to prevent CMV infection in stem cell transplant patients
This study is testing a new vaccine to see if it can help prevent CMV infections in patients receiving stem cell transplants from related donors.
-
Using cord blood transplant and chemotherapy to treat high-risk blood cancers
This study is testing if combining umbilical cord blood transplants with certain chemotherapy treatments can help people with high-risk blood cancers do better and have fewer side effects.
-
Reduced-intensity conditioning to lower treatment-related mortality in stem cell transplant patients
This study is testing a new way to prepare patients for a stem cell transplant to see if it can lower the risk of serious treatment-related complications.
-
Donor stem cell transplant with chemotherapy and radiation for blood cancers
This study is testing if a donor stem cell transplant combined with different doses of chemotherapy and radiation can help people with blood cancers recover better.
-
HA-1 TCR T cell therapy for leukemia that returned or didn't respond after a donor stem cell transplant
This Phase 1 study will test whether giving specially engineered donor T cells called HA-1 TCR T cells is safe and what dose works for people whose acute leukemia came back or didn't respond after a donor stem cell transplant.
Related topics
Quick answers
How many Chronic Myeloid Leukemia, BCR-ABL1 Positive clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.